HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$0.70
Day range
$0.71 - $0.83
Year range
$0.70 - $11.40
Market cap
35.63M USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | -1.78M | -161.06% |
Operating expense | 18.49M | -30.40% |
Net income | -22.86M | 7.83% |
Net profit margin | 1.28K | 250.96% |
Earnings per share | -0.49 | 9.26% |
EBITDA | -20.46M | 14.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.96M | -72.77% |
Total assets | 32.93M | -66.11% |
Total liabilities | 66.98M | 22.12% |
Total equity | -34.05M | — |
Shares outstanding | 45.60M | — |
Price to book | -0.94 | — |
Return on assets | -121.88% | — |
Return on capital | -224.69% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -22.86M | 7.83% |
Cash from operations | -8.56M | 42.22% |
Cash from investing | -16.00K | 75.38% |
Cash from financing | -397.00K | -100.90% |
Net change in cash | -8.97M | -130.76% |
Free cash flow | -966.00K | 84.79% |
About
CEO
Founded
2013
Headquarters
Website
Employees
100
